Cohen Klingenstein LLC's Q4 2022 vs. Q1 2023 13F Holdings Comparison: Changes in Top Holdings and Value
Ava Hoppe | 6 May, 2023
Cohen Klingenstein LLC, an investment management company that manages over $2 billion in assets, recently filed its 13F report with the Securities and Exchange Commission (SEC) for the fourth quarter of 2022 and the first quarter of 2023. The report lists the company's top holdings, the number of shares held, and the total value of those holdings.
In this article, we would be analyzing the changes in the top holdings and the value of Cohen Klingenstein LLC's portfolio between the Q4 2022 and Q1 2023 13F report. We would also be discussing some of the key holdings in the portfolio.
Top Holdings in Cohen Klingenstein LLC's Portfolio
As of Q1 2023, the top five holdings in the company's portfolio are SPDR S&P 500 ETF Trust (SPY), iShares Russell 2000 Growth ETF (IWO), Apple Inc (AAPL), Microsoft Corporation (MSFT), and Invesco QQQ Trust (QQQ). These holdings have remained the same since Q4 2022.
Between Q4 2022 and Q1 2023, the top three holdings by value saw an increase in their total value. The value of SPDR S&P 500 ETF Trust (SPY) increased by 7.1% to $310,788,000, iShares Russell 2000 Growth ETF (IWO) increased by 3.7% to $130,207,000, and Invesco QQQ Trust (QQQ) increased by 20.5% to $111,847,000.
While the number of shares of some of the top holdings remained the same between Q4 2022 and Q1 2023, the total value of some of the holdings decreased. For instance, the total value of Apple Inc (AAPL) shares held by Cohen Klingenstein LLC decreased by 26.9% to $111,733,000.
Other notable holdings that saw significant increases in their total value include Nvidia Corporation (NVDA) with a total value increase of 90.1%, Meta Platforms Inc (META) with a total value increase of 76.1%, and Tesla Inc (TSLA) with a total value increase of 70.1%.
Holdings That Decreased in Value
On the other hand, some holdings in Cohen Klingenstein LLC's portfolio decreased in value between Q4 2022 and Q1 2023. Eli Lilly (LLY) saw the largest decrease in total value, dropping by 6.1% to $49,062,000. Procter & Gamble (PG) and Johnson & Johnson (JNJ) also saw a decrease in total value by 1.9% and 12.7%, respectively.
Other holdings that decreased in value include Pfizer Inc (PFE) with a total value decrease of 20.4%, Bank of America Corporation (BAC) with a total value decrease of 13.7%, and Honeywell International Inc (HON) with a total value decrease of 11.5%.
Conclusion
In summary, Cohen Klingenstein LLC's Q4 2022 vs. Q1 2023 13F holdings comparison shows that the company's top holdings have remained the same, but there have been some significant changes in the total value of its holdings. While some holdings have seen an increase in value, others have seen a decrease. As an investor, it's essential to keep an eye on such changes in holdings and values as they can provide valuable insights into the current market trends and the company's investment strategies.
Other Posts
- The Shift in Investment Strategy: Valueworks LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison
- Ridgemont Equity Partners Leads Recapitalization of smartShift
- Congress Park Capital LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- A Look at Brasada Capital Management's Q3 and Q4 2022 13F Filings: Insights into Stock Selection and Investment Strategy
- CenterOak Partners Acquires Guardian Access Solutions
- Navigating New Horizons: Corpay's Strategic Leap in EMEA with Oliver Morris at the Helm
- Brilliance Asset Management's Q3 vs Q4 2022 13F Holdings Report: Key Takeaways
- Pomona Investment Fund: Offering Easy Access to Private Equity Investments on iCapital Marketplace
- Private Equity: Fueling Growth and Job Creation for Inc. 5000 Awardees
- PFG Advisors Q3 2023 vs. Q4 2023 13F Holdings Comparison